title: Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosis.
authors.forename: Rémy
authors.initials: R
authors.lastname: Phan-Ba
authors.forename: Nadine
authors.initials: N
authors.lastname: Lambinet
authors.forename: Edouard
authors.initials: E
authors.lastname: Louis
authors.forename: Philippe
authors.initials: P
authors.lastname: Delvenne
authors.forename: Luaba
authors.initials: L
authors.lastname: Tshibanda
authors.forename: Jacques
authors.initials: J
authors.lastname: Boverie
authors.forename: Gustave
authors.initials: G
authors.lastname: Moonen
authors.forename: Shibeshih
authors.initials: S
authors.lastname: Belachew
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002446:Celiac Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D000069442:Natalizumab; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab